- Your Selections:
- 8 results
- Sort By:
- Popularity
- Date
- Name
Advances and Emerging Trends in the Swiss Biotech Market
10:00 AM - 10:45 AM on Monday, Apr 22, 2013
Description:
Switzerland is a leader in biotechnology innovation. Its geographic position, industry and the variety of academia and non-profit organizations have helped the country forge a unique cluster for the development of...
Finding Your Niche
10:15 AM - 11:30 AM on Monday, Apr 22, 2013
Description:
Rising regulatory and reimbursement hurdles are putting pressure on biopharma’s commercial engines, and redefining the term "blockbuster." Part of the industry’s response has been to embrace more niche indications, where lower...
How IP Issues Impact Innovations in Biomarker Diagnostics & Personalized Medicine
10:15 AM - 11:30 AM on Monday, Apr 22, 2013
Description:
Advances in personalized medicine and diagnostic technologies have been made possible by innovators who have done the difficult work to assess and clinically validate which biomarker measurements are relevant to disease...
Allies in Innovation: Biologics and Cell Therapy Manufacturers Think Small for Big Value
2:30 PM - 3:30 PM on Monday, Apr 22, 2013
Description:
As biologic and cell therapies that open the door to more personalized and targeted medicine gain momentum, the bioprocessing and cell therapy industries are advancing more cost-effective and flexible technologies for...
Circulating Tumor Cells (CTC): From Enumeration to Comprehensive Molecular Characterization
2:30 PM - 3:30 PM on Monday, Apr 22, 2013
Description:
Inexpensive, minimally-invasive diagnostics tests are important for the effective development of targeted cancer therapies because they can be used repeatedly throughout the course of disease to assess the effect, and even...
Physiology First: Back to the Future in Drug Discovery
2:30 PM - 3:30 PM on Monday, Apr 22, 2013
Description:
Targeted therapies have dominated drug discovery for the past 10–15 years. As industry roll-ups and other issues squeeze innovation to a trickle, new approaches achieve new priority. The earliest drug discovery...
Thriving, Not Just Surviving: FDA Advisory Committee Meetings
2:30 PM - 3:30 PM on Monday, Apr 22, 2013
Description:
For many biotech executives, the term "FDA advisory committee meeting" evokes feelings of fear, even among those with historical experience. Instead of tackling Advisory Committee (Ad Com) hearings as times of...
Fly Me to the Immune: Advances in Cancer Immunotherapy
3:45 PM - 5:00 PM on Monday, Apr 22, 2013
Description:
When the FDA approved the first therapeutic cancer vaccine in 2010, expectations soared, but commercially, the drug has fallen short of expectations so far. What is next on the immunotherapy landscape?...